SEC Company Response from Pulmatrix, Inc. (PULM) (CIK 0001574235) (PULM) — Mar 28, 2018
Pulmatrix, Inc. (PULM) (CIK 0001574235)
Date: March 28, 2018 · CIK: 0001574235 · Accession: 0001193125-18-098973
AI Filing Summary & Sentiment
File numbers found in text: 333-223630
Letter
OPPENHEIMER & CO. INC.
85 Broad Street
New York, New York 10004
March 28, 2018
VIA EDGAR
United States Securities and Exchange Commission
Division of Corporation Finance
100 F Street, N.E.
Washington, D.C. 20549
Re: Pulmatrix, Inc.
Registration Statement, as amended on Form S-1 (File No. 333-223630)
Ladies and Gentlemen:
In accordance with the above-referenced Registration Statement, and pursuant to Rule 461 of the General Rules and Regulations of the Securities and Exchange Commission under the Securities Act of 1933, as amended (the “Securities Act”), the undersigned, as the representative of the several underwriters (the “Representative”), hereby joins in the request of Pulmatrix, Inc. that the effective date of the above-referenced Registration Statement be accelerated so that it will be declared effective at 4:00 p.m., Eastern Time, on Wednesday, March 28, 2018, or as soon thereafter as practicable.
Pursuant to Rule 460 under the Securities Act, please be advised that there will be distributed to each underwriter or dealer, who is reasonably anticipated to be invited to participate in the distribution of the security, as many copies of the proposed form of preliminary prospectus as appears to be reasonable to secure adequate distribution of the preliminary prospectus.
The undersigned, as the representative of the several underwriters, represents that the several underwriters have and will comply with the requirements of Rule 15c2-8 under the Securities Exchange Act of 1934, as amended.
Very truly yours,
OPPENHEIMER & CO. INC.
Show Raw Text
CORRESP 1 filename1.htm CORRESP OPPENHEIMER & CO. INC. 85 Broad Street New York, New York 10004 March 28, 2018 VIA EDGAR United States Securities and Exchange Commission Division of Corporation Finance 100 F Street, N.E. Washington, D.C. 20549 Re: Pulmatrix, Inc. Registration Statement, as amended on Form S-1 (File No. 333-223630) Ladies and Gentlemen: In accordance with the above-referenced Registration Statement, and pursuant to Rule 461 of the General Rules and Regulations of the Securities and Exchange Commission under the Securities Act of 1933, as amended (the “Securities Act”), the undersigned, as the representative of the several underwriters (the “Representative”), hereby joins in the request of Pulmatrix, Inc. that the effective date of the above-referenced Registration Statement be accelerated so that it will be declared effective at 4:00 p.m., Eastern Time, on Wednesday, March 28, 2018, or as soon thereafter as practicable. Pursuant to Rule 460 under the Securities Act, please be advised that there will be distributed to each underwriter or dealer, who is reasonably anticipated to be invited to participate in the distribution of the security, as many copies of the proposed form of preliminary prospectus as appears to be reasonable to secure adequate distribution of the preliminary prospectus. The undersigned, as the representative of the several underwriters, represents that the several underwriters have and will comply with the requirements of Rule 15c2-8 under the Securities Exchange Act of 1934, as amended. Very truly yours, OPPENHEIMER & CO. INC. As representative of the several Underwriters OPPENHEIMER & CO. INC. By: /s/ Douglas Cameron Name: Douglas Cameron Title: Head of Equity Capital Markets